NEW YORK (GenomeWeb News) – A new consortium has been launched in Europe with the goal of developing a handheld molecular diagnostic device to test for malaria.

The Nanomal project is led by researchers at St. George's, University College London and molecular diagnostics firm QuantuMDx and has been provided with funding of €5.2 million ($6.7 million) from the European Commission's Seventh Framework Programme. Other participants in the consortium include the University of Tuebingen in Germany and the Karolinska Institute in Sweden.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Genome Research this week: mitochondrial and nuclear gene fusions in cancer, role of genomic imprinting in tissue-specific gene expression, and more.

Maria Freire from the Foundation for the NIH calls for "politically popular pledges of support" for the NIH to turn into support for increased funding for the agency.

A Thomson Reuters analysis indicates that the life sciences, rather than the tech sector, are increasingly driving global innovation.

The White House says ethical discussions about genome editing of the human germline are needed.